Cancer drug can reactivate HIV
A team of scientists have recently discovered how a new drug called JQ1 which is currently in early-phase human cancer trials, can reactivate latent HIV...
List view / Grid view
News
Metal simplifies synthesis of antibody drugs
Scientists have developed a method to efficiently modify natural antibodies that can deliver drugs to target cells...
Novartis receives EU approval for ribociclib
Novartis announced that the European Commission approved ribociclib in combination with an aromatase inhibitor for treatment of postmenopausal women with metastatic breast cancer
Infrared spectroscopy could reduce dependence on colonoscopy
A fast, simple blood test for ulcerative colitis using infrared spectroscopy may provide a cheaper, less invasive alternative for screening compared to colonoscopy...
Steroids not effective for chest infections in non-asthmatic adults
Oral steroids should not be used for treating acute lower respiratory tract infection in adults who don't have asthma or other chronic lung disease...
Artificial intelligence predicts dementia before onset of symptoms
Scientists have used artificial intelligence capable of recognising the signatures of dementia two years before its onset...
Cancer Research UK launches trial to test new drug
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK...
FDA evaluates prescription opioid medications approved for children
The FDA has heard from professional groups, including the American Academy of Paediatrics about the use of opioid cough suppressants for children...
Lab Innovations continues its successful partnership with the Royal Society of Chemistry
Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – returns to the NEC, Birmingham, for its sixth consecutive year on the 1st and 2nd of November 2017...
Superbug squashed by super-team of antibiotics
Researchers have found that a novel combination of antibiotics that was able to kill E. coli carrying mcr-1 and ndm-5 genes within 24 hours...
Biochemical fingerprints reveal diabetes progression
Researchers have described a new method to study biochemical changes that occur in the pancreas during the development of diabetes...
Lasers used to detect risk of heart attack and stroke
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light...
Venture launched for a novel compound against malaria
A patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite has been launched...
FDA grants approval of Besponsa for acute lymphoblastic leukaemia
The FDA has approved Besponsa for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia...
FDA grants two orphan drug designations for HCC
The FDA has granted two orphan drug designations for T cell therapy products for the treatment of hepatocellular carcinoma...
